Streltima 130 mg

Streltima 130 mg is a medicine authorised by Swissmedic under authorisation number 70523. The authorisation holder is Janssen-Cilag AG. The medicinal product code is Biotechnological medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 30 September 2025 and the authorisation is limited until 30 September 2026. ATC code L04AC05 places the medicine in the group Immunosuppressants.

  • Dispensing category B
  • Authorisation number 70523
  • ATC L04AC05
  • Biotechnological medicines
Authorisation data
Authorisation number70523
NameStreltima 130 mg
Full nameStreltima 130 mg, Konzentrat zur Herstellung einer Infusionslösung
Authorisation holderJanssen-Cilag AG
Medicinal product codeBiotechnological medicines
Dispensing categoryB · Prescription only
ATC codeL04AC05
First authorisation30 September 2025
Authorisation validity30 September 2026
Strengths
No.NameDispensing categoryAuthorisation date
1Streltima 130 mg, Konzentrat zur Herstellung einer InfusionslösungB30 September 2025

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
11Durchstechflasche(n)L04AC0507.15.0.B

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Streltima 130 mg authorised in Switzerland?

Yes. Streltima 130 mg is authorised by Swissmedic under authorisation number 70523, data as of 01 September 2026. The authorisation is limited until 30 September 2026.

Which dispensing category does Streltima 130 mg have?

Streltima 130 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of Streltima 130 mg?

The authorisation holder is Janssen-Cilag AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com